News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
760,796 Results
Type
Article (46725)
Company Profile (230)
Press Release (713829)
Multimedia
Podcasts (140)
Webinars (23)
Section
Business (242777)
Career Advice (2133)
Deals (36994)
Drug Delivery (148)
Drug Development (84732)
Employer Resources (177)
FDA (17082)
Job Trends (15615)
News (360038)
Policy (34386)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (6)
Academia (2738)
Accelerated approval (57)
ADA (44)
Adcomms (33)
Allergies (202)
Alliances (51898)
ALS (232)
Alzheimer's disease (1901)
Antibody-drug conjugate (ADC) (549)
Approvals (17555)
Artificial intelligence (784)
ASCO (336)
Autoimmune disease (366)
Automation (65)
Bankruptcy (377)
Best Places to Work (11815)
BIO (70)
BIOSECURE Act (21)
Biosimilars (251)
Biotechnology (151)
Bladder cancer (209)
Brain cancer (80)
Breast cancer (823)
Cancer (6534)
Cardiovascular disease (526)
Career advice (1821)
Career pathing (46)
CAR-T (369)
CDC (69)
Celiac Disease (3)
Cell therapy (1006)
Cervical cancer (57)
Clinical research (73964)
Collaboration (2330)
Commercialization (1)
Company closure (5)
Compensation (1543)
Complete response letters (97)
COVID-19 (2940)
CRISPR (125)
C-suite (1309)
Cystic fibrosis (163)
Data (8835)
Decentralized trials (3)
Denatured (42)
Depression (184)
Dermatology (103)
Diabetes (686)
Diagnostics (7167)
Digital health (65)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (385)
Drug pricing (222)
Drug shortages (34)
Duchenne muscular dystrophy (314)
Earnings (94187)
Editorial (73)
Employer branding (21)
Employer resources (158)
Events (124537)
Executive appointments (1175)
FDA (21223)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (36)
Funding (1913)
Gene editing (260)
Generative AI (66)
Gene therapy (789)
GLP-1 (1153)
Government (4979)
Grass and pollen (8)
Guidances (422)
Healthcare (19486)
Hematology (196)
HIV (94)
Huntington's disease (65)
IgA nephropathy (118)
Immunology and inflammation (341)
Immuno-oncology (117)
Indications (224)
Infectious disease (3332)
Inflammatory bowel disease (234)
Inflation Reduction Act (14)
Influenza (149)
Intellectual property (328)
Interviews (336)
IPO (17021)
IRA (57)
Job creations (4087)
Job search strategy (1512)
JPM (66)
Kidney cancer (22)
Labor market (114)
Layoffs (620)
Leadership (44)
Legal (8452)
Liver cancer (107)
Longevity (36)
Lung cancer (866)
Lymphoma (485)
Machine learning (68)
Management (62)
Manufacturing (1221)
Marketing (5)
MASH (217)
Medical affairs (1)
Medical device (14103)
Medtech (14283)
Mergers & acquisitions (21300)
Metabolic disorders (1715)
mRNA (261)
Multiple sclerosis (206)
NASH (18)
Neurodegenerative disease (479)
Neuropsychiatric disorders (116)
Neuroscience (3600)
Neurotech (1)
NextGen: Class of 2026 (6728)
Non-profit (4631)
Now hiring (83)
Obesity (791)
Opinion (327)
Ovarian cancer (246)
Pain (288)
Pancreatic cancer (361)
Parkinson's disease (402)
Partnered (37)
Patents (659)
Patient recruitment (798)
Peanut (70)
People (62254)
Pharmaceutical (53)
Pharmacy benefit managers (35)
Phase 1 (23053)
Phase 2 (32538)
Phase 3 (24278)
Pipeline (10187)
Policy (361)
Postmarket research (2695)
Preclinical (9876)
Press Release (70)
Prostate cancer (343)
Psychedelics (63)
Radiopharmaceuticals (362)
Rare diseases (1249)
Real estate (6331)
Recruiting (73)
Regulatory (27034)
Reports (58)
Research institute (2540)
Resumes & cover letters (365)
Rett syndrome (46)
RNA editing (28)
RSV (98)
Schizophrenia (193)
Series A (329)
Series B (240)
Service/supplier (7)
Sickle cell disease (126)
Special edition (28)
Spinal muscular atrophy (172)
Sponsored (49)
Startups (3849)
State (2)
Stomach cancer (19)
Supply chain (139)
Tariffs (99)
The Weekly (95)
Vaccines (1270)
Venture capital (128)
Weight loss (513)
Women's health (139)
Worklife (21)
Date
Today (26)
Last 7 days (421)
Last 30 days (2046)
Last 365 days (31138)
2026 (17215)
2025 (30877)
2024 (35884)
2023 (40887)
2022 (52116)
2021 (56663)
2020 (55145)
2019 (47673)
2018 (35980)
2017 (33381)
2016 (32952)
2015 (38839)
2014 (32730)
2013 (27853)
2012 (29978)
2011 (30709)
2010 (28739)
Location
Africa (826)
Alabama (95)
Alaska (7)
Arizona (375)
Arkansas (16)
Asia (43432)
Australia (7035)
California (14242)
Canada (4037)
China (1576)
Colorado (609)
Connecticut (619)
Delaware (439)
Europe (93936)
Florida (2158)
Georgia (451)
Hawaii (3)
Idaho (63)
Illinois (1186)
India (105)
Indiana (644)
Iowa (24)
Japan (616)
Kansas (137)
Kentucky (52)
Louisiana (60)
Maine (91)
Maryland (1691)
Massachusetts (10280)
Michigan (380)
Minnesota (767)
Mississippi (6)
Missouri (153)
Montana (36)
Nebraska (30)
Nevada (152)
New Hampshire (84)
New Jersey (3722)
New Mexico (32)
New York (3764)
North Carolina (1805)
North Dakota (9)
Northern California (7186)
Ohio (421)
Oklahoma (24)
Oregon (43)
Pennsylvania (2827)
Puerto Rico (31)
Rhode Island (52)
South America (1192)
South Carolina (90)
South Dakota (2)
Southern California (5660)
Tennessee (232)
Texas (2293)
United States (50400)
Utah (425)
Vermont (2)
Virginia (357)
Washington D.C. (81)
Washington State (1157)
West Virginia (4)
Wisconsin (143)
Wyoming (2)
760,796 Results for "immune pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pancreatic cancer
ASCO: Biopharma has pancreatic cancer ‘surrounded’ as Immuneering’s drug adds 9 quality months
In addition to eliciting 17.3 months median overall survival vs. 8.5 months for patients given standard of care treatment in a prior study, Immuneering’s atebimetinib demonstrated a robust tolerability profile—something CEO Ben Zeskind said equates highly with survival.
June 1, 2026
·
5 min read
·
Heather McKenzie
Press Releases
Immunic, Inc. Announces 1-for-10 Reverse Stock Split
April 23, 2026
·
7 min read
Venture capital
Big Pharma–backed Coultreon bags $125M series A to unlock alternative immune pathway
Coultreon Biopharma is advancing assets that target salt-inducible kinases, proteins that drive inflammation and other immune-mediated conditions.
April 28, 2026
·
2 min read
·
Tristan Manalac
Pancreatic cancer
Can Revolution’s ‘miracle’ pancreatic cancer drug be topped? Immuneering, Actuate say yes
Last month, Revolution Medicines’ RAS inhibitor doubled survival in a Phase 3 pancreatic cancer trial. On the biotech’s heels are Immuneering, Actuate Therapeutics, Erasca and more, looking to improve on that result with increased tolerability—and more time for patients.
May 18, 2026
·
7 min read
·
Heather McKenzie
Press Releases
Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study
June 1, 2026
·
6 min read
Press Releases
TRexBio Announces Pipeline Progress, Naming TRB-071 as a CD30 Agonist for Immune-Mediated Diseases and Advancement of Lilly-Partnered TRB-051
June 30, 2026
·
3 min read
Press Releases
Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio
June 28, 2026
·
5 min read
Press Releases
Novartis to highlight Rhapsido® data across multiple immune-mediated diseases at EAACI Congress 2026
June 8, 2026
·
6 min read
Press Releases
Immuneering Appoints Andrew Gengos as Chief Financial Officer
June 15, 2026
·
6 min read
Press Releases
Immunic to Participate in Investor Conferences in July 2026
July 9, 2026
·
4 min read
1 of 76,080
Next
